Beauty brewing biological manufacturing bill, CXO in batches, Hang Seng Medical ETF (513060) premium

Relevant leaders of the United States signed an administrative order to encourage American biotechnology production and research on the 12th local time.The order aims to promote the American manufacturing of the pharmaceutical industry and agriculture, plastics and energy.

Affected by this news, today's CXO sector fell in batches, Yaoming creatures fell more than 19%, Wuhan Kangde fell more than 15%, and Kang Long turned into nearly 13%.Hang Seng Medical ETF (513060) large proportion of large proportions covered with the market, which fell 2.29%today, and continued to premium on the market, with a turnover of over 400 million yuan.

Guojin Securities said that in combination with the analysis of the previous report, after the interim reported, the performance of the medical sector's enterprise low has been established, and the growth rate of corporate performance in Q3/Q4 and even 2023 is expected to recover.Considering the overall position and valuation of the pharmaceutical and medical sector are also at a historical low, the medical sector is expected to have a full background in terms of policy expectations, performance, positions, and valuations, which is worthy of grasp.

- END -